Skip to content
The Nexus
DossierENTITY

Adalimumab

Coverage of Adalimumab in the Nexus archive.

Earliest in view: Jul 20 · 03:39 UTCMost recent: Jul 20 · 03:39 UTC
Co-mentioned in this coverage
Drug Regulatory Authority of Pakistanorganization1Pakistan Chemists and Druggists Associationorganization1Pakistan Pharmaceutical Manufacturers Associationorganization1Keytruda (Pembrolizumab)topic1Abdul Samad Buddaniperson1Pakistanplace1Humador insulintopic1
Recent coverage
  • HEALTHJul 20 · 03:39 UTCDAWN
    40 registered life-saving medicines remain out of patients’ reach

    Around 40 life-saving medicines registered in Pakistan remain unavailable to patients due to delayed federal price approvals, forcing reliance on smuggled or unregistered drugs for conditions like cancer, diabetes, and haemophilia. The medicines, including Keytruda and Adalimumab, have completed regulatory processes but await price notifications since December 2024.

Adalimumab · Dossier · The Nexus